Cargando…

Stereospecific targeting of MTH1 by (S)-crizotinib as anticancer strategy

Activated Ras GTPase signalling is a critical driver of oncogenic transformation and malignant disease. Cellular models of RAS-dependent cancers have been used to identify experimental small-molecules, such as SCH51344, but their molecular mechanism of action remains generally enigmatic. Here, using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huber, Kilian V. M., Salah, Eidarus, Radic, Branka, Gridling, Manuela, Elkins, Jonathan M., Stukalov, Alexey, Jemth, Ann-Sofie, Gokturk, Camilla, Sanjiv, Kumar, Strömberg, Kia, Pham, Therese, Berglund, Ulrika Warpman, Colinge, Jacques, Bennett, Keiryn L., Loizou, Joanna, Helleday, Thomas, Knapp, Stefan, Superti-Furga, Giulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150021/ https://www.ncbi.nlm.nih.gov/pubmed/24695225 http://dx.doi.org/10.1038/nature13194

Ejemplares similares

Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2
por: Carter, Megan, et al.
Publicado: (2015)

MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool
por: Scaletti, Emma Rose, et al.
Publicado: (2020)

Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
por: Pudelko, Linda, et al.
Publicado: (2017)

MutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP
por: Jemth, Ann-Sofie, et al.
Publicado: (2018)

Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
por: Pudelko, Linda, et al.
Publicado: (2020)

Affinity Purification Strategies for Proteomic Analysis of Transcription Factor Complexes
por: Giambruno, Roberto, et al.
Publicado: (2013)

AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma
por: Das, Ishani, et al.
Publicado: (2020)

Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action
por: Babak, Maria V., et al.
Publicado: (2015)

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model
por: Moukengue, Brice, et al.
Publicado: (2020)

A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL
por: Rix, Uwe, et al.
Publicado: (2013)

Functional Dissection of the TBK1 Molecular Network
por: Goncalves, Adriana, et al.
Publicado: (2011)

MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia
por: Sanjiv, Kumar, et al.
Publicado: (2021)

Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species
por: Qing, Xiangcheng, et al.
Publicado: (2018)

A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
por: Fauster, A, et al.
Publicado: (2015)

Initial characterization of the human central proteome
por: Burkard, Thomas R, et al.
Publicado: (2011)

The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production
por: Eberle, Carol-Ann, et al.
Publicado: (2014)

Proteome-wide small molecule and metabolite interaction mapping
por: Huber, Kilian V. M., et al.
Publicado: (2015)

(S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1
por: Dai, Xuanxuan, et al.
Publicado: (2017)

Karonudib is a promising anticancer therapy in hepatocellular carcinoma
por: Hua, Xiangwei, et al.
Publicado: (2019)

Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations
por: Niu, Yuzhen, et al.
Publicado: (2015)

hMYH and hMTH1 cooperate for survival in mismatch repair defective T-cell acute lymphoblastic leukemia
por: Eshtad, S, et al.
Publicado: (2016)

Global survey of the immunomodulatory potential of common drugs
por: Vladimer, Gregory I., et al.
Publicado: (2017)

Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms
por: Li, Jiannong, et al.
Publicado: (2013)

Mutations in Cancer Cause Gain of Cysteine, Histidine, and Tryptophan at the Expense of a Net Loss of Arginine on the Proteome Level
por: Tsuber, Viktoriia, et al.
Publicado: (2017)

A Computational Approach to Analyze the Mechanism of Action of the Kinase Inhibitor Bafetinib
por: Burkard, Thomas R., et al.
Publicado: (2010)

Introduction to Computational Proteomics
por: Colinge, Jacques, et al.
Publicado: (2007)

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
por: Li, Jiannong, et al.
Publicado: (2010)

In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
por: Michel, Maurice, et al.
Publicado: (2020)

Building and exploring an integrated human kinase network: Global organization and medical entry points()
por: Colinge, Jacques, et al.
Publicado: (2014)

Overexpressed c-Myc Sensitizes Cells to TH1579, a Mitotic Arrest and Oxidative DNA Damage Inducer
por: Henriksson, Sofia, et al.
Publicado: (2022)

CD14 is a coreceptor of Toll-like receptors 7 and 9
por: Baumann, Christoph L., et al.
Publicado: (2010)

Adaptation to Chronic-Cycling Hypoxia Renders Cancer Cells Resistant to MTH1-Inhibitor Treatment Which Can Be Counteracted by Glutathione Depletion
por: Hansel, Christine, et al.
Publicado: (2021)

NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres during Mitosis
por: Zhao, Zhenjun, et al.
Publicado: (2021)

MTH1 counteracts oncogenic oxidative stress
por: Burton, Dominick G.A., et al.
Publicado: (2015)

Polyamine block of MthK potassium channels
por: Nimigean, Crina M.
Publicado: (2020)

The allosteric gating mechanism of the MthK channel
por: Guan, Fenghui, et al.
Publicado: (2022)

Stereospecific pharmacokinetic characterization of liquiritigenin in the rat
por: Alrushaid, Samaa, et al.
Publicado: (2017)

Comparative docking analysis of cholesterol analogs to ion channels to discriminate between stereospecific binding vs. stereospecific response
por: Barbera, Nicolas A., et al.
Publicado: (2019)

Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
por: Radic-Sarikas, Branka, et al.
Publicado: (2017)

MTH1 Substrate Recognition—An Example of Specific Promiscuity
por: Nissink, J. Willem M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mp4fbv2nfeedp7b8bi6hbibodh